Synthekine Alternatives & Competitors
12 companies similar to Synthekine — Synthekine a biotechnology company focused on discovery and developing best in c...
Companies similar to Synthekine
Bright Peak Therapeutics
Better Biologics Through Chemistry
Basel, Switzerland
-logo.jpg "VBL Therapeutics (Nasdaq:VBLT)"){kind=logo}
VBL Therapeutics (Nasdaq:VBLT)
Engineering the future of targeted medicines, breaking barriers to develop the next genera...
Israel
Xencor
Proteins by Design
Pasadena, United States
Thymmune Therapeutics
Biotech firm developing thymic cell therapies to restore immune function using machine lea...
Cambridge, United States
Track all Synthekine competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Walking Fish Therapeutics, Inc.
Engineering B Cell‐Based Protein Factories to Treat Serious Diseases.
South San Francisco, Unit...
Outpace Bio
Revolutionizing Cell Therapy with Protein Design
Seattle, United States
ImmunGene
Innovation in antibody-cytokine fusion technology and monoclonal antibody-based therapies...
Immunaeon
Connecting Today's Science to Tomorrow's Cures
Buffalo, United States
Harmonic Discovery
Embedding the complexity of disease into the drug discovery process
New York, United States
Vicinitas Therapeutics
Advancing a one-of-a-kind protein stabilization platform to develop novel therapeutics for...
South San Francisco, Unit...
Ixaka
An integrated cell and gene therapy company focused on the natural power of the body to cu...
London, United Kingdom
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly select...
Boston, United States
About Synthekine
Synthekine, founded in 2018, is a biotechnology company headquartered in the United States, focused on engineered cytokine therapeutics for cancer and autoimmune disorders. By leveraging immunological insights and targeted protein engineering, Synthekine aims to discover and develop groundbreaking treatments. The compa...
Research and Development of Cytokine Therapeutics, Cytokine Partial Agonists, Surrogate Cytokine Agonists
Cancer Patients, Patients with Autoimmune Diseases, Healthcare Providers, Pharmaceutical Partners
Cytokine Therapeutics, Immunotherapy, Cancer Treatment, Autoimmune Disorders, Protein Engineering, Cytokine Partial Agonism, Immunological Specificity, Preclinical Studies, Safety And Efficacy, Targeted Protein Engineering, Modified Cytokines, Cytokine-enhanced Cell Therapies, Surrogate Cytokine Agonists, Inflammatory Disease Treatment
B2B, B2B2C
Licensing, Performance Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Synthekine and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Synthekine on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
